Lenva
Lenva is Lenvatinib, an oral multi-targeted tyrosine kinase inhibitor. It is indicated for differentiated thyroid cancer, hepatocellular carcinoma, renal cell carcinoma, and other selected tumors and works by inhibiting angiogenic and oncogenic signaling pathways.
Features
| Product Name | Lenva |
| Generic Name | Lenvatinib |
| Formulation | Capsule |
| Available Pack Size | 2X6's, 2X8's |
| Available Strength | 4 mg, 10 mg |